After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NVO belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – General industry. The current market capitalization of Novo Nordisk ADR is $239.03B. A total of 6.37 million shares were traded on the day, compared to an average of 10.12M shares.
In the most recent transaction, Novo Nordisk A/S bought 921,897 shares of NVO for 2.14 per share on May 30 ’25.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Novo Nordisk ADR pays an annual dividend of $1.66, resulting in a dividend yield of 2.34%, and it has a price to earnings (P/E) ratio of 21.06.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NVO has a high of $143.49 and a low of $57.00.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NVO’s latest balance sheet shows that the firm has $17.48B in Cash & Short Term Investments as of fiscal 2021. There were $26.64B in debt and $99.52B in liabilities at the time. Its Book Value Per Share was $4.52, while its Total Shareholder’s Equity was $70.75B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVO is Buy with a score of 3.61.
